Cargando…
Azithromycin effectively inhibits tumor angiogenesis by suppressing vascular endothelial growth factor receptor 2-mediated signaling pathways in lung cancer
Tumor angiogenesis is essential during lung cancer development and targeting angiogenesis may possess a potential therapeutic value. The present study demonstrates that azithromycin, a Food and Drug Administration-approved antibiotic drug, is a novel tumor angiogenesis inhibitor. Azithromycin inhibi...
Autores principales: | Li, Fajiu, Huang, Jie, Ji, Dongyuan, Meng, Qinghua, Wang, Chuanhai, Chen, Shi, Wang, Xiaojiang, Zhu, Zhiyang, Jiang, Cheng, Shi, Yi, Liu, Shuang, Li, Chenghong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5494938/ https://www.ncbi.nlm.nih.gov/pubmed/28693139 http://dx.doi.org/10.3892/ol.2017.6103 |
Ejemplares similares
-
The miR‐124‐3p regulates the allergic airway inflammation and remodeling in an ovalbumin‐asthmatic mouse model by inhibiting S100A4
por: Liu, Min, et al.
Publicado: (2023) -
Luteolin Inhibits Human Prostate Tumor Growth by Suppressing Vascular Endothelial Growth Factor Receptor 2-Mediated Angiogenesis
por: Pratheeshkumar, Poyil, et al.
Publicado: (2012) -
Endothelial deletion of SHP2 suppresses tumor angiogenesis and promotes vascular normalization
por: Xu, Zhiyong, et al.
Publicado: (2021) -
Interlocking detachable coil embolization for giant tandem bronchial aneurysms: A case report
por: Chen, Yingjie, et al.
Publicado: (2021) -
Study of the Regulatory Mechanism of miR-26a-5p in Allergic Asthma
por: Zhong, Jinnan, et al.
Publicado: (2022)